T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV‐1 patients

Introduction: Restriction factors (RFs) suppress HIV‐1 in cell lines and primary cell models. Hence, RFs might be attractive targets for novel antiviral strategies, but their importance for virus control in vivo is controversial. Methods: We profiled the expression of RFs in primary blood‐derived mo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the International AIDS Society 2017, Vol.20 (1), p.21865-n/a
Hauptverfasser: Bolduan, Sebastian, Koppensteiner, Herwig, Businger, Ramona, Rebensburg, Stephanie, Kunze, Christine, Brack‐Werner, Ruth, Draenert, Rika, Schindler, Michael
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 1
container_start_page 21865
container_title Journal of the International AIDS Society
container_volume 20
creator Bolduan, Sebastian
Koppensteiner, Herwig
Businger, Ramona
Rebensburg, Stephanie
Kunze, Christine
Brack‐Werner, Ruth
Draenert, Rika
Schindler, Michael
description Introduction: Restriction factors (RFs) suppress HIV‐1 in cell lines and primary cell models. Hence, RFs might be attractive targets for novel antiviral strategies, but their importance for virus control in vivo is controversial. Methods: We profiled the expression of RFs in primary blood‐derived mononuclear cells (PBMC) from therapy‐naïve HIV‐1 patients and quantified infection. Results: Overall, there was no correlation between individual RF expression and HIV‐1 status in total PBMC. However, we identified a T cell population with low levels of intracellular CD2 and reduced expression of SAMHD1, p21 and SerinC5. CD2low T cells with reduced RF expression were markedly positive for HIV‐1 p24. In contrast, CD2+ T cells were less infected and expressed higher levels of RFs. CD2low T cell infection correlated with viral loads and was associated with HIV‐1 disease progression. Conclusions: In untreated therapy naïve chronic HIV‐1 patients, RF expression in T cells is associated with CD2 expression and seems to influence viral loads. Our study suggests that RFs help to control HIV‐1 infection in certain T cells in vivo and supports the potential for RFs as promising targets for therapeutic intervention.
doi_str_mv 10.7448/IAS.20.1.21865
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5964667</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A518588519</galeid><sourcerecordid>A518588519</sourcerecordid><originalsourceid>FETCH-LOGICAL-c7635-d4cfe12fa201ef03a4a4147169fd77a158fb0a2d4781b88468ba4492420bf8323</originalsourceid><addsrcrecordid>eNqNk8-O0zAQxiMEYpeFK0dkCWnFpcF2HNu5IFXlzxatxIGFq-U6TuOVaxc7aemNMyfehIfgTXgS3O1StVCWVaQ4sn_zfePJTJY9RjBnhPDn4-H7HMMc5RhxWt7JjhEr-QDTEt_d-T7KHsR4CSHFnFT3syPMq7IoMDvOvl4Apa2NYGm6Fli_BKOXGFi90GlPf54HHSMIuu6VrtMau2BUZ7wDjVSdDxFIVwMZNEhko4N2nZHWroBxjVZdijEOdK0Ocr4CTv74vtBAtcE7o8DZ-OPPL98QmMvOpLj4MLvXSBv1o-v1JPvw-tXF6Gxw_u7NeDQ8HyhGi3JQE9VohBuJIdINLCSRBBGGaNXUjElU8mYCJa4J42jCOaF8IgmpMMFw0vACFyfZi43uvJ_MdK2Sd5BWzIOZybASXhqxf-JMK6Z-IcqKEkpZEnh2LRD8pz7VRMxMXFdROu37KFBFikTykif06R_ope-DS9cTBaSMIlJdZfRPCuMKFpCz9N5SU2m1SAX2KTu1thbDEiU3XqLqZgpWiGIG146DA9RUu_SnrHe6MWl7T_VW_I5-foBPT61nRh00uF3AjsPpTkCrpe3a6G2_bs64r3wz-HfOKvgYUztvWwJBsR42kYZNYCiQuBq2FPBkt5G2-O_pSgDZAMuU_Oo_cuLteLjR_QVMizEP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2290308790</pqid></control><display><type>article</type><title>T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV‐1 patients</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><creator>Bolduan, Sebastian ; Koppensteiner, Herwig ; Businger, Ramona ; Rebensburg, Stephanie ; Kunze, Christine ; Brack‐Werner, Ruth ; Draenert, Rika ; Schindler, Michael</creator><creatorcontrib>Bolduan, Sebastian ; Koppensteiner, Herwig ; Businger, Ramona ; Rebensburg, Stephanie ; Kunze, Christine ; Brack‐Werner, Ruth ; Draenert, Rika ; Schindler, Michael</creatorcontrib><description>Introduction: Restriction factors (RFs) suppress HIV‐1 in cell lines and primary cell models. Hence, RFs might be attractive targets for novel antiviral strategies, but their importance for virus control in vivo is controversial. Methods: We profiled the expression of RFs in primary blood‐derived mononuclear cells (PBMC) from therapy‐naïve HIV‐1 patients and quantified infection. Results: Overall, there was no correlation between individual RF expression and HIV‐1 status in total PBMC. However, we identified a T cell population with low levels of intracellular CD2 and reduced expression of SAMHD1, p21 and SerinC5. CD2low T cells with reduced RF expression were markedly positive for HIV‐1 p24. In contrast, CD2+ T cells were less infected and expressed higher levels of RFs. CD2low T cell infection correlated with viral loads and was associated with HIV‐1 disease progression. Conclusions: In untreated therapy naïve chronic HIV‐1 patients, RF expression in T cells is associated with CD2 expression and seems to influence viral loads. Our study suggests that RFs help to control HIV‐1 infection in certain T cells in vivo and supports the potential for RFs as promising targets for therapeutic intervention.</description><identifier>ISSN: 1758-2652</identifier><identifier>EISSN: 1758-2652</identifier><identifier>DOI: 10.7448/IAS.20.1.21865</identifier><identifier>PMID: 28953327</identifier><language>eng</language><publisher>Switzerland: International AIDS Society</publisher><subject>Acquired immune deficiency syndrome ; Adult ; Aged ; AIDS ; AIDS/HIV ; Antiviral agents ; Cells ; Cloning ; Control ; Dosage and administration ; Drug therapy ; Experiments ; Female ; Health aspects ; Hepatitis ; HIV ; HIV infections ; HIV Infections - genetics ; HIV Infections - immunology ; HIV Infections - virology ; HIV patients ; HIV-1 - physiology ; HIV‐1 ; Human immunodeficiency virus ; Humans ; Immune system ; in vivo relevance ; Infections ; Interferon ; Leukocytes, Mononuclear - immunology ; Leukocytes, Mononuclear - virology ; Lymphocytes ; Male ; Middle Aged ; p21 ; Patients ; Physiological aspects ; Proteins ; restriction factors ; RISP ; SAM Domain and HD Domain-Containing Protein 1 - genetics ; SAM Domain and HD Domain-Containing Protein 1 - immunology ; SAMHD1 ; SerinC5 ; T cells ; T-Lymphocytes - immunology ; T-Lymphocytes - virology ; Tetherin ; Viral Load ; Viruses</subject><ispartof>Journal of the International AIDS Society, 2017, Vol.20 (1), p.21865-n/a</ispartof><rights>2017 Bolduan S et al; licensee International AIDS Society</rights><rights>COPYRIGHT 2017 International AIDS Society</rights><rights>2017. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Bolduan S et al; licensee International AIDS Society. The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c7635-d4cfe12fa201ef03a4a4147169fd77a158fb0a2d4781b88468ba4492420bf8323</citedby><cites>FETCH-LOGICAL-c7635-d4cfe12fa201ef03a4a4147169fd77a158fb0a2d4781b88468ba4492420bf8323</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964667/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964667/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,1417,4024,11562,27923,27924,27925,45574,45575,46052,46476,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28953327$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bolduan, Sebastian</creatorcontrib><creatorcontrib>Koppensteiner, Herwig</creatorcontrib><creatorcontrib>Businger, Ramona</creatorcontrib><creatorcontrib>Rebensburg, Stephanie</creatorcontrib><creatorcontrib>Kunze, Christine</creatorcontrib><creatorcontrib>Brack‐Werner, Ruth</creatorcontrib><creatorcontrib>Draenert, Rika</creatorcontrib><creatorcontrib>Schindler, Michael</creatorcontrib><title>T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV‐1 patients</title><title>Journal of the International AIDS Society</title><addtitle>J Int AIDS Soc</addtitle><description>Introduction: Restriction factors (RFs) suppress HIV‐1 in cell lines and primary cell models. Hence, RFs might be attractive targets for novel antiviral strategies, but their importance for virus control in vivo is controversial. Methods: We profiled the expression of RFs in primary blood‐derived mononuclear cells (PBMC) from therapy‐naïve HIV‐1 patients and quantified infection. Results: Overall, there was no correlation between individual RF expression and HIV‐1 status in total PBMC. However, we identified a T cell population with low levels of intracellular CD2 and reduced expression of SAMHD1, p21 and SerinC5. CD2low T cells with reduced RF expression were markedly positive for HIV‐1 p24. In contrast, CD2+ T cells were less infected and expressed higher levels of RFs. CD2low T cell infection correlated with viral loads and was associated with HIV‐1 disease progression. Conclusions: In untreated therapy naïve chronic HIV‐1 patients, RF expression in T cells is associated with CD2 expression and seems to influence viral loads. Our study suggests that RFs help to control HIV‐1 infection in certain T cells in vivo and supports the potential for RFs as promising targets for therapeutic intervention.</description><subject>Acquired immune deficiency syndrome</subject><subject>Adult</subject><subject>Aged</subject><subject>AIDS</subject><subject>AIDS/HIV</subject><subject>Antiviral agents</subject><subject>Cells</subject><subject>Cloning</subject><subject>Control</subject><subject>Dosage and administration</subject><subject>Drug therapy</subject><subject>Experiments</subject><subject>Female</subject><subject>Health aspects</subject><subject>Hepatitis</subject><subject>HIV</subject><subject>HIV infections</subject><subject>HIV Infections - genetics</subject><subject>HIV Infections - immunology</subject><subject>HIV Infections - virology</subject><subject>HIV patients</subject><subject>HIV-1 - physiology</subject><subject>HIV‐1</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Immune system</subject><subject>in vivo relevance</subject><subject>Infections</subject><subject>Interferon</subject><subject>Leukocytes, Mononuclear - immunology</subject><subject>Leukocytes, Mononuclear - virology</subject><subject>Lymphocytes</subject><subject>Male</subject><subject>Middle Aged</subject><subject>p21</subject><subject>Patients</subject><subject>Physiological aspects</subject><subject>Proteins</subject><subject>restriction factors</subject><subject>RISP</subject><subject>SAM Domain and HD Domain-Containing Protein 1 - genetics</subject><subject>SAM Domain and HD Domain-Containing Protein 1 - immunology</subject><subject>SAMHD1</subject><subject>SerinC5</subject><subject>T cells</subject><subject>T-Lymphocytes - immunology</subject><subject>T-Lymphocytes - virology</subject><subject>Tetherin</subject><subject>Viral Load</subject><subject>Viruses</subject><issn>1758-2652</issn><issn>1758-2652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNqNk8-O0zAQxiMEYpeFK0dkCWnFpcF2HNu5IFXlzxatxIGFq-U6TuOVaxc7aemNMyfehIfgTXgS3O1StVCWVaQ4sn_zfePJTJY9RjBnhPDn4-H7HMMc5RhxWt7JjhEr-QDTEt_d-T7KHsR4CSHFnFT3syPMq7IoMDvOvl4Apa2NYGm6Fli_BKOXGFi90GlPf54HHSMIuu6VrtMau2BUZ7wDjVSdDxFIVwMZNEhko4N2nZHWroBxjVZdijEOdK0Ocr4CTv74vtBAtcE7o8DZ-OPPL98QmMvOpLj4MLvXSBv1o-v1JPvw-tXF6Gxw_u7NeDQ8HyhGi3JQE9VohBuJIdINLCSRBBGGaNXUjElU8mYCJa4J42jCOaF8IgmpMMFw0vACFyfZi43uvJ_MdK2Sd5BWzIOZybASXhqxf-JMK6Z-IcqKEkpZEnh2LRD8pz7VRMxMXFdROu37KFBFikTykif06R_ope-DS9cTBaSMIlJdZfRPCuMKFpCz9N5SU2m1SAX2KTu1thbDEiU3XqLqZgpWiGIG146DA9RUu_SnrHe6MWl7T_VW_I5-foBPT61nRh00uF3AjsPpTkCrpe3a6G2_bs64r3wz-HfOKvgYUztvWwJBsR42kYZNYCiQuBq2FPBkt5G2-O_pSgDZAMuU_Oo_cuLteLjR_QVMizEP</recordid><startdate>2017</startdate><enddate>2017</enddate><creator>Bolduan, Sebastian</creator><creator>Koppensteiner, Herwig</creator><creator>Businger, Ramona</creator><creator>Rebensburg, Stephanie</creator><creator>Kunze, Christine</creator><creator>Brack‐Werner, Ruth</creator><creator>Draenert, Rika</creator><creator>Schindler, Michael</creator><general>International AIDS Society</general><general>John Wiley &amp; Sons, Inc</general><general>Taylor &amp; Francis</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>2017</creationdate><title>T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV‐1 patients</title><author>Bolduan, Sebastian ; Koppensteiner, Herwig ; Businger, Ramona ; Rebensburg, Stephanie ; Kunze, Christine ; Brack‐Werner, Ruth ; Draenert, Rika ; Schindler, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c7635-d4cfe12fa201ef03a4a4147169fd77a158fb0a2d4781b88468ba4492420bf8323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Adult</topic><topic>Aged</topic><topic>AIDS</topic><topic>AIDS/HIV</topic><topic>Antiviral agents</topic><topic>Cells</topic><topic>Cloning</topic><topic>Control</topic><topic>Dosage and administration</topic><topic>Drug therapy</topic><topic>Experiments</topic><topic>Female</topic><topic>Health aspects</topic><topic>Hepatitis</topic><topic>HIV</topic><topic>HIV infections</topic><topic>HIV Infections - genetics</topic><topic>HIV Infections - immunology</topic><topic>HIV Infections - virology</topic><topic>HIV patients</topic><topic>HIV-1 - physiology</topic><topic>HIV‐1</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Immune system</topic><topic>in vivo relevance</topic><topic>Infections</topic><topic>Interferon</topic><topic>Leukocytes, Mononuclear - immunology</topic><topic>Leukocytes, Mononuclear - virology</topic><topic>Lymphocytes</topic><topic>Male</topic><topic>Middle Aged</topic><topic>p21</topic><topic>Patients</topic><topic>Physiological aspects</topic><topic>Proteins</topic><topic>restriction factors</topic><topic>RISP</topic><topic>SAM Domain and HD Domain-Containing Protein 1 - genetics</topic><topic>SAM Domain and HD Domain-Containing Protein 1 - immunology</topic><topic>SAMHD1</topic><topic>SerinC5</topic><topic>T cells</topic><topic>T-Lymphocytes - immunology</topic><topic>T-Lymphocytes - virology</topic><topic>Tetherin</topic><topic>Viral Load</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bolduan, Sebastian</creatorcontrib><creatorcontrib>Koppensteiner, Herwig</creatorcontrib><creatorcontrib>Businger, Ramona</creatorcontrib><creatorcontrib>Rebensburg, Stephanie</creatorcontrib><creatorcontrib>Kunze, Christine</creatorcontrib><creatorcontrib>Brack‐Werner, Ruth</creatorcontrib><creatorcontrib>Draenert, Rika</creatorcontrib><creatorcontrib>Schindler, Michael</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the International AIDS Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bolduan, Sebastian</au><au>Koppensteiner, Herwig</au><au>Businger, Ramona</au><au>Rebensburg, Stephanie</au><au>Kunze, Christine</au><au>Brack‐Werner, Ruth</au><au>Draenert, Rika</au><au>Schindler, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV‐1 patients</atitle><jtitle>Journal of the International AIDS Society</jtitle><addtitle>J Int AIDS Soc</addtitle><date>2017</date><risdate>2017</risdate><volume>20</volume><issue>1</issue><spage>21865</spage><epage>n/a</epage><pages>21865-n/a</pages><issn>1758-2652</issn><eissn>1758-2652</eissn><abstract>Introduction: Restriction factors (RFs) suppress HIV‐1 in cell lines and primary cell models. Hence, RFs might be attractive targets for novel antiviral strategies, but their importance for virus control in vivo is controversial. Methods: We profiled the expression of RFs in primary blood‐derived mononuclear cells (PBMC) from therapy‐naïve HIV‐1 patients and quantified infection. Results: Overall, there was no correlation between individual RF expression and HIV‐1 status in total PBMC. However, we identified a T cell population with low levels of intracellular CD2 and reduced expression of SAMHD1, p21 and SerinC5. CD2low T cells with reduced RF expression were markedly positive for HIV‐1 p24. In contrast, CD2+ T cells were less infected and expressed higher levels of RFs. CD2low T cell infection correlated with viral loads and was associated with HIV‐1 disease progression. Conclusions: In untreated therapy naïve chronic HIV‐1 patients, RF expression in T cells is associated with CD2 expression and seems to influence viral loads. Our study suggests that RFs help to control HIV‐1 infection in certain T cells in vivo and supports the potential for RFs as promising targets for therapeutic intervention.</abstract><cop>Switzerland</cop><pub>International AIDS Society</pub><pmid>28953327</pmid><doi>10.7448/IAS.20.1.21865</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1758-2652
ispartof Journal of the International AIDS Society, 2017, Vol.20 (1), p.21865-n/a
issn 1758-2652
1758-2652
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5964667
source MEDLINE; DOAJ Directory of Open Access Journals; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection); PubMed Central
subjects Acquired immune deficiency syndrome
Adult
Aged
AIDS
AIDS/HIV
Antiviral agents
Cells
Cloning
Control
Dosage and administration
Drug therapy
Experiments
Female
Health aspects
Hepatitis
HIV
HIV infections
HIV Infections - genetics
HIV Infections - immunology
HIV Infections - virology
HIV patients
HIV-1 - physiology
HIV‐1
Human immunodeficiency virus
Humans
Immune system
in vivo relevance
Infections
Interferon
Leukocytes, Mononuclear - immunology
Leukocytes, Mononuclear - virology
Lymphocytes
Male
Middle Aged
p21
Patients
Physiological aspects
Proteins
restriction factors
RISP
SAM Domain and HD Domain-Containing Protein 1 - genetics
SAM Domain and HD Domain-Containing Protein 1 - immunology
SAMHD1
SerinC5
T cells
T-Lymphocytes - immunology
T-Lymphocytes - virology
Tetherin
Viral Load
Viruses
title T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV‐1 patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T22%3A29%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=T%20cells%20with%20low%20CD2%20levels%20express%20reduced%20restriction%20factors%20and%20are%20preferentially%20infected%20in%20therapy%20na%C3%AFve%20chronic%20HIV%E2%80%901%20patients&rft.jtitle=Journal%20of%20the%20International%20AIDS%20Society&rft.au=Bolduan,%20Sebastian&rft.date=2017&rft.volume=20&rft.issue=1&rft.spage=21865&rft.epage=n/a&rft.pages=21865-n/a&rft.issn=1758-2652&rft.eissn=1758-2652&rft_id=info:doi/10.7448/IAS.20.1.21865&rft_dat=%3Cgale_pubme%3EA518588519%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2290308790&rft_id=info:pmid/28953327&rft_galeid=A518588519&rfr_iscdi=true